Infection Control Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

The infection control market is projected to register a CAGR of 6.5% during the forecast period (2021-2026).

The infection control market is primarily driven by the high prevalence of nosocomial infections and the growing number of surgeries that require control measures to stop spreading. According to the Centers for Disease Control and Prevention (CDC), about one in every 20 patients admitted for the treatment will develop a nosocomial infection. Hospital-acquired infections result in more than 99,000 deaths each year. ​The lack of awareness regarding infection control and stringent regulatory requirements are anticipated to impede market growth. However, the government and non-government organizations' initiatives regarding infection control, coupled with the growing control measures by the healthcare providers in hospitals, are expected to drive the market growth. For instance, in January 2020, The Ministry of Health and Population has launched the second phase of Infection Control Initiatives in nine governorates of Egypt.

Key Market Trends

Sterilization Products and Services are Anticipated to Have Significant Share

Sterilization is important to control infectious diseases that may exist everywhere in hospitals or healthcare facilities, and it is debatable whether antibiotics can control such an extensive attack.

The sterilization products and services segment under the product and services segment is anticipated to have lucrative growth owing to the increasing need to reduce hospital-acquired infection and extensive use of sterilization equipment in the healthcare settings. According to the World Health Organization (WHO), at least 30 new diseases emerged in the last 20 years, and infectious diseases kill 17 million people every year.

Moreover, an increasing number of surgeries, increasing prevalence of infectious diseases, and growth in the healthcare industry are anticipated to boost the market growth over the forecast period.

In the end-user segments, the hospital is anticipated to have a significant growth due to the increasing adoption of infection control products due to increasing number of patient suffering from COVID-19 and stringent regulations by the respective governments to control the infections.

North America is Expected to Witness Significant Growth

North America is anticipated to have the significant growth owing to well-established healthcare infrastructure, high adoption of infection control technologies, and the presence of the key market players in the region. Furthermore, the initiatives are taken by the government authorities in infection control and recent product launches. For instance, Getinge AB has launched a new 9100E Cart Washer in the United States for the healthcare industry.

On the other hand, the Asia Pacific region is anticipated to have lucrative market growth due to the growing healthcare industry, increasing disposable income, and expanding healthcare providers' investments in infection control. Moreover, infection control initiatives and the growing number of hospital-acquired infections in the region are anticipated to boost the market growth over the forecast period.

Competitive Landscape

The global infection control market is moderately fragmented and competitive. Market players are focusing on new product launches, product innovations, and geographical expansion to strengthen its market share. The key market players operating in the market include Fortive (Advanced Sterilization Products), 3M Company, Getinge AB, Steris PLC, and Cantel Medical Corporation.

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support